Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

/PRNewswire/ — Citius Oncology, Inc. (“Citius Oncology” or the “Company”) (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and…
Share This Post
Related Articles

The PTS Blog

Subscribe to our blog to stay up to date on the latest HCM, Data, Recruiting, Technology, and Software trends.

Top Posts From PTS
Explore

View our White Papers

View our Case Studies

Receive the latest updates

Subscribe To
Our Quarterly Newsletter

Get notified about new blog posts, case studies, white papers, and more!